Beyond Weight Loss: New Research Suggests Semaglutide May Delay Biological Aging and Extend Lifespan
The pharmacological landscape surrounding GLP-1 receptor agonists—a class of drugs that includes semaglutide, the active ingredient in Ozempic and Wegovy—is undergoing a significant paradigm shift. While these medications were originally…
Weight-loss drug semaglutide reduces heavy alcohol drinking in new clinical trial
A landmark clinical trial has demonstrated that semaglutide, the active pharmaceutical ingredient in widely used weight-loss and diabetes medications such as Wegovy and Ozempic, may offer a significant new therapeutic…








